{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:58:29Z","timestamp":1777420709089,"version":"3.51.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062647","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T21:14:03Z","timestamp":1366838043000},"page":"e62647","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["A School-Based Human Papillomavirus Vaccination Program in Barretos, Brazil: Final Results of a Demonstrative Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Jos\u00e9 Humberto Tavares Guerreiro","family":"Fregnani","sequence":"first","affiliation":[]},{"given":"Andr\u00e9 Lopes","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Eluf-Neto","sequence":"additional","affiliation":[]},{"given":"Karina de C\u00e1ssia Braga","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Larissa de Melo","family":"Kuil","sequence":"additional","affiliation":[]},{"given":"Tauana Arcadepani","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Silvia Lapola","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Edmundo Carvalho","family":"Mauad","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Luisa Lina","family":"Villa","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"D Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S3\/52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: Epidemiology and transmission dynamics of genital HPV infection","volume":"24","author":"AN Burchell","year":"2006","journal-title":"Vaccine"},{"key":"ref3","unstructured":"WHO (2011) Initiative for Vaccine Research (IVR) - Viral Cancer - HPV. World Health Organization."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"J Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"ref5","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, <etal>et al<\/etal>. (2011) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S3\/11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"DM Parkin","year":"2006","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases","volume":"356","author":"SM Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"LL Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"J Paavonen","year":"2009","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"M Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2010.12.002","article-title":"HPV prophylactic vaccination: The first years and what to expect from now","volume":"305","author":"LL Villa","year":"2011","journal-title":"Cancer Lett"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"LL Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women","volume":"85","author":"CK Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"JM Brotherton","year":"2011","journal-title":"Lancet"},{"key":"ref16","first-page":"118","article-title":"Human papillomavirus vaccines. WHO position paper","volume":"15","year":"2009","journal-title":"Weekly Epidemiological Record"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.vaccine.2012.04.087","article-title":"Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: A dynamic individual-based approach","volume":"30","author":"T Vanni","year":"2012","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16, 18 vaccination in Brazil","volume":"25","author":"SJ Goldie","year":"2007","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1753-6405.2009.00409.x","article-title":"Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia","volume":"33","author":"M Watson","year":"2009","journal-title":"Aust N Z J Public Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ypmed.2011.08.015","article-title":"Adolescent and young adult HPV vaccination in Australia: achievements and challenges","volume":"53","author":"SM Garland","year":"2011","journal-title":"Prev Med"},{"key":"ref21","unstructured":"(2011) Immunise Australia Program. Human Papillomavirus (HPV). Information about the National Human Papillomavirus (HPV) Vaccination Program funded under the Immunise Australia Program.: Australian Government. Depatment of Health and Aging."},{"key":"ref22","first-page":"615","article-title":"Human papilloma virus vaccination in Nepal: an initial experience in Nepal","volume":"11","author":"Y Singh","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2471\/BLT.11.089862","article-title":"Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries","volume":"89","author":"DS LaMontagne","year":"2011","journal-title":"Bull World Health Organ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1471-2458-12-370","article-title":"Assessment of eight HPV vaccination programs implemented in lowest income countries","volume":"12","author":"J Ladner","year":"2012","journal-title":"BMC Public Health"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/infdis\/jis407","article-title":"Human papillomavirus vaccination in tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies","volume":"206","author":"D Watson-Jones","year":"2012","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.vaccine.2009.12.042","article-title":"Determinants for HPV vaccine uptake in the Netherlands: A multilevel study","volume":"28","author":"M Rondy","year":"2010","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/j.vaccine.2011.04.007","article-title":"Assessment of the first HPV vaccination campaign in two northern Italian health districts","volume":"29","author":"GM Chadenier","year":"2011","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jadohealth.2010.04.006","article-title":"Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches","volume":"47","author":"R Rouzier","year":"2010","journal-title":"J Adolesc Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2011.02.064","article-title":"HPV vaccination in France: uptake, costs and issues for the National Health Insurance","volume":"29","author":"JP Fagot","year":"2011","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Simoens C, Sabbe M, Van Damme P, Beutels P, Arbyn M (2009) Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007\u20132008. Euro Surveill 14.","DOI":"10.2807\/ese.14.46.19407-en"},{"key":"ref31","unstructured":"(2010) National, state, and local area vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2009. MMWR Center for Disease Control and Prevention\/US. 1018\u20131023."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1016\/j.vaccine.2011.10.021","article-title":"Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark","volume":"29","author":"K Widgren","year":"2011","journal-title":"Vaccine"},{"key":"ref33","first-page":"671","article-title":"National and State Vaccination Coverage Among Adolescents Aged 13\u201317 years \u2013 United States, 2011","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Limia A, Pachon I (2011) Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill 16.","DOI":"10.2807\/ese.16.21.19873-en"},{"key":"ref35","first-page":"1382","article-title":"Progress toward implementation of human papillomavirus vaccination\u2013the Americas, 2006\u20132010","volume":"60","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref36","unstructured":"Brasil (2010) Censo 2010. Instituto Brasileiro de Geografia e Estat\u00edstica."},{"key":"ref37","unstructured":"WHO (2012) Immunization Summary. A statistical reference containg data through 2010 (the 2012 edition). World Health Organization. 198."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1542\/peds.2011-1048","article-title":"Adolescent vaccination-coverage levels in the United States: 2006\u20132009","volume":"128","author":"S Stokley","year":"2011","journal-title":"Pediatrics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.vaccine.2012.01.032","article-title":"Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey","volume":"30","author":"S Arrossi","year":"2012","journal-title":"Vaccine"},{"key":"ref40","unstructured":"Brazil (2011) SI-PNI - Sistema de Informa\u00e7\u00e3o do Programa Nacional de Imuniza\u00e7\u00f5es [National Immunization Program Information System]. Brasilia: Minist\u00e9rio da Sa\u00fade [Minister of Health]."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T19:27:41Z","timestamp":1644866861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062647"}},"subtitle":[],"editor":[{"given":"Silvia","family":"de Sanjose","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062647","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,24]]}}}